Fred Alger Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,000	Closed	-$114K	–	549
2018 Q1	$114K	Buy	+4,000	New	+$114K	﹤0.01%	403
2017 Q3	–	Sell	-5,000	Closed	-$78K	–	518
2017 Q2	$78K	Buy	+5,000	New	+$78K	﹤0.01%	406